Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-06

Clinical Trial Update: mTBI Identification and Monitoring Through Retinal Scanning

View source ↗

Summary

Recruiting study to identify and monitor mild traumatic brain injury through retinal scanning. Sponsored by Rebiscan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rebiscan, Inc. | Conditions: Brain Injuries, Traumatic | Status: RECRUITING